Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunome (IMNM) Current Leases (2023 - 2024)

Historic Current Leases for Immunome (IMNM) over the last 2 years, with Q4 2024 value amounting to $63000.0.

  • Immunome's Current Leases fell 7967.74% to $63000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $63000.0, marking a year-over-year decrease of 7967.74%. This contributed to the annual value of $63000.0 for FY2024, which is 7967.74% down from last year.
  • According to the latest figures from Q4 2024, Immunome's Current Leases is $63000.0, which was down 7967.74% from $257000.0 recorded in Q3 2024.
  • Over the past 5 years, Immunome's Current Leases peaked at $310000.0 during Q4 2023, and registered a low of $63000.0 during Q4 2024.